HuGE Literature Finder
|
||
Records 1-54
|
Pharmacogenetic analysis of opioid dependence treatment dose and dropout rate.
The American journal of drug and alcohol abuse 2018 Jan 1-10. Crist Richard C, Li James, Doyle Glenn A, Gilbert Alex, Dechairo Bryan M, Berrettini Wade |
|
Potential role of patients' CYP3A-status in clozapine pharmacokinetics.
The international journal of neuropsychopharmacology 2017 Mar . Tóth Katalin, Csukly Gábor, Sirok Dávid, Belic Ales, Kiss Ádám, Háfra Edit, Déri Máté, Menus Ádám, Bitter István, Monostory Katal |
|
Genetic Determinants of Clozapine-Induced Metabolic Side Effects.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2016 Sep . Vasudev Kamini, Choi Yun-Hee, Norman Ross, Kim Richard B, Schwarz Ute |
|
CYP gene family variants as a potential risk factors in drug addiction in Han Chinese.
The journal of gene medicine 2016 Jun . Zhang Hongxing, Yang Qi, Zheng Wenkai, Ouyang Yongri, Yang Min, Wang Fengjiao, Jin Tianbo, Zhang Ji, Wang Zhenyu |
|
Cigarette smoking has a differential effect on the plasma level of clozapine in Taiwanese schizophrenic patients associated with the CYP1A2 gene -163A/C single nucleotide polymorphism.
Psychiatric genetics 2016 May . Huang Hui-Ching, Lua Ahai Chang, Wu Lawrence Shih-Hsin, Wu Bo-Jian, Lee Shin-Min, Liu Chao-Zo |
|
CYP1A2 and CYP2D6 Gene Polymorphisms in Schizophrenic Patients with Neuroleptic Drug-Induced Side Effects.
Bulletin of experimental biology and medicine 2016 Mar 160 (5): 687-90. Ivanova S A, Filipenko M L, Vyalova N M, Voronina E N, Pozhidaev I V, Osmanova D Z, Ivanov M V, Fedorenko O Yu, Semke A V, Bokhan N |
|
The CYP1A2 -163C>A polymorphism is associated with super-refractory schizophrenia.
Schizophrenia research 2015 Oct . de Brito Rodrigo Bernini, de Carvalho Araújo Leandro, Diniz Mateus José Abdalla, de Castro Georg Raphaela, Nabout João Carlos, Vianelo Rosana Pereira, da Silva Santos Rodrigo, da Silva Cruz Aline Helena, Ghedini Paulo Cés |
|
CYP1A2*1D and *1F polymorphisms have a significant impact on olanzapine serum concentrations.
Therapeutic drug monitoring 2015 Apr 37 (2): 152-60. Czerwensky Fabian, Leucht Stefan, Steimer Wern |
|
Cytochrome P450 1A2 co-determines neuroleptic load and may diminish tardive dyskinesia by increased inducibility.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2015 Apr 16 (3): 200-5. Ivanova Svetlana A, Toshchakova Valentina A, Filipenko Maxim L, Fedorenko Olga Yu, Boyarko Evgenia G, Boiko Anastasia S, Semke Arkadiy V, Bokhan Nikolay A, Aftanas Lyubomir I, Loonen Anton J |
|
Genetic variation in melatonin pathway enzymes in children with autism spectrum disorder and comorbid sleep onset delay.
Journal of autism and developmental disorders 2015 Jan 45 (1): 100-10. Veatch Olivia J, Pendergast Julie S, Allen Melissa J, Leu Roberta M, Johnson Carl Hirschie, Elsea Sarah H, Malow Beth |
|
Neither cytochrome P450 family genes nor neuroendocrine factors could independently predict the SSRIs treatment in the Chinese Han population.
Pharmacopsychiatry 2014 Mar 47 (2): 60-6. Zhang X, Yu T, Li X, Li X, Huang X, Li X, He L, He G, Sun |
|
CYP1A2 polymorphism -1545C > T (rs2470890) is associated with increased side effects to clozapine.
BMC psychiatry 2014 14 (1): 50. Viikki Merja, Kampman Olli, Seppälä Niko, Mononen Nina, Lehtimäki Terho, Leinonen E |
|
Influence of FMO1 and 3 polymorphisms on serum olanzapine and its N-oxide metabolite in psychiatric patients.
The pharmacogenomics journal 2013 Dec 13 (6): 544-50. Söderberg M M, Haslemo T, Molden E, Dahl M |
|
Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting.
Pharmacogenetics and genomics 2013 Oct 23 (10): 535-48. Hall-Flavin Daniel K, Winner Joel G, Allen Josiah D, Carhart Joseph M, Proctor Brian, Snyder Karen A, Drews Maureen S, Eisterhold Linda L, Geske Jennifer, Mrazek David |
|
The CYP1A2 -163C>A polymorphism is associated with clozapine-induced generalized tonic-clonic seizures in Brazilian schizophrenia patients.
Psychiatry research 2013 Sep 209 (2): 242-5. Kohlrausch Fabiana Barzotti, Severino-Gama Clarissa, Lobato Maria Inês, Belmonte-de-Abreu Paulo, Carracedo Angel, Hutz Mara Hele |
|
CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions.
Pharmacogenomics 2013 Jul 14 (10): 1191-201. Kuo Hsiang-Wei, Liu Shu Chih, Tsou Hsiao-Hui, Liu Sheng-Wen, Lin Keh-Ming, Lu Shao-Chun, Hsiao Mei-Chun, Hsiao Chin-Fu, Liu Chia-Yih, Chen Chia-Hui, Lu Mong-Liang, Shen Winston W, Tang Hwa-Sheng, Liu Shen-Ing, Chang Liang-Huey, Wu Hsiao-Yu, Chang Yao-Sheng, Yeh Teng-Kuang, Chen Andrew Ch, Liu Yu- |
|
Association between CYP1A2 polymorphisms and clozapine-induced adverse reactions in patients with schizophrenia.
Psychiatry research 2012 Dec 200 (2-3): 1014-7. Ferrari Marco, Bolla Emilio, Bortolaso Paola, Callegari Camilla, Poloni Nicola, Lecchini Sergio, Vender Simone, Marino Franca, Cosentino Mar |
|
Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depression.
Journal of clinical psychopharmacology 2012 Oct 32 (5): 622-9. Jaquenoud Sirot Eveline, Harenberg Sabine, Vandel Pierre, Lima Carlos A Mendonça, Perrenoud Patrick, Kemmerling Klaus, Zullino Daniele F, Hilleret Henriette, Crettol Séverine, Jonzier-Perey Michèle, Golay Kerry Powell, Brocard Muriel, Eap Chin B, Baumann Pier |
|
The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorder.
European archives of psychiatry and clinical neuroscience 2012 Oct . Höfer P, Schosser A, Calati R, Serretti A, Massat I, Kocabas NA, Konstantinidis A, Linotte S, Mendlewicz J, Souery D, Zohar J, Juven-Wetzler A, Montgomery S, Kasper S |
|
Association study of 27 annotated genes for clozapine pharmacogenetics: validation of preexisting studies and identification of a new candidate gene, ABCB1, for treatment response.
Journal of clinical psychopharmacology 2012 Aug 32 (4): 441-8. Lee Seung-Tae, Ryu Seunghyong, Kim Suk-Ran, Kim Min-Ji, Kim Seonwoo, Kim Jong-Won, Lee Soo-Youn, Hong Kyung S |
|
Candidate gene-based association study of antipsychotic-induced movement disorders in long-stay psychiatric patients: a prospective study.
PloS one 2012 7 (5): e36561. Bakker P Roberto, Bakker Egbert, Amin Najaf, van Duijn Cornelia M, van Os Jim, van Harten Peter |
|
CYP2D6 genotype and smoking influence fluvoxamine steady-state concentration in Japanese psychiatric patients: lessons for genotype-phenotype association study design in translational pharmacogenetics.
Journal of psychopharmacology (Oxford, England) 2011 Jul 25 (7): 908-14. Suzuki Yutaro, Sugai Takuro, Fukui Naoki, Watanabe Junzo, Ono Shin, Inoue Yoshimasa, Ozdemir Vural, Someya Toshiyu |
|
High correlation between serum and cerebrospinal fluid olanzapine concentrations in patients with schizophrenia or schizoaffective disorder medicating with oral olanzapine as the only antipsychotic drug.
Journal of clinical psychopharmacology 2011 Feb 31 (1): 4-9. Skogh Elisabeth, Sjödin Ingemar, Josefsson Martin, Dahl Marja-Lii |
|
Xenobiotic metabolizing and transporter genes: gene-gene interactions in schizophrenia and related disorders.
Pharmacogenomics 2010 Dec 11 (12): 12. Gassó P, Mas S, Alvarez S, Trias G, Bioque M, Oliveira C, Bernardo M, Lafuente A |
|
A large-scale candidate gene association study of age at menarche and age at natural menopause.
Human genetics 2010 Nov 128 (5): 515-27. He Chunyan, Kraft Peter, Chasman Daniel I, Buring Julie E, Chen Constance, Hankinson Susan E, Paré Guillaume, Chanock Stephen, Ridker Paul M, Hunter David |
|
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine.
Pharmacogenomics 2010 Nov 11 (11): 1535-43. Lin Keh-Ming, Tsou Hsiao-Hui, Tsai I-Ju, Hsiao Mei-Chun, Hsiao Chin-Fu, Liu Chia-Yih, Shen Winston W, Tang Hwa-Sheng, Fang Chun-Kai, Wu Chi-Shin, Lu Shao-Chun, Kuo Hsiang-Wei, Liu Shu Chih, Chan Hsiu-Wen, Hsu Ya-Ting, Tian Jia-Ni, Liu Yu- |
|
Genetic associations of brain structural networks in schizophrenia: a preliminary study.
Biological psychiatry 2010 Oct 68 (7): 657-66. Jagannathan Kanchana, Calhoun Vince D, Gelernter Joel, Stevens Michael C, Liu Jingyu, Bolognani Federico, Windemuth Andreas, Ruaño Gualberto, Assaf Michal, Pearlson Godfrey |
|
Genetic polymorphisms related to efficacy and overuse of triptans in chronic migraine.
The journal of headache and pain 2010 Oct 11 (5): 431-5. Gentile Giovanna, Borro Marina, Lala Noemi, Missori Serena, Simmaco Maurizio, Martelletti Pao |
|
Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure--an impact similar to male gender or smoking in schizophrenic patients.
European journal of clinical pharmacology 2010 May 66 (5): 465-74. Ghotbi Roza, Mannheimer Buster, Aklillu Eleni, Suda Akira, Bertilsson Leif, Eliasson Erik, Osby Urb |
|
Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome.
The pharmacogenomics journal 2010 Feb 10 (1): 20-9. Laika B, Leucht S, Heres S, Schneider H, Steimer |
|
Development of a high throughput single nucleotide polymorphism screening method for the cytochrome P450 1A2 polymorphisms CYP1A2*1C and CYP1A2*1F: are they useful as predictive markers in mental disorders?
Clinical laboratory 2010 56 (9-10): 473-80. Klemm Marco, Eidens Moritz, Lorenz Marion, Prause Stefan, Weise Alexander, Dahmen Norbert, Forst Thomas, Pfützner Andre |
|
[Population pharmacokinetics research of clozapine in Chinese schizophrenic patients].
Yao xue xue bao = Acta pharmaceutica Sinica 2009 Jul 44 (7): 785-92. Qiu Xue-Wen, Fu Pei-Xin, Wang Chuan-Yue, Liu Min, Zhou Tian-Yan, Lu W |
|
Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients.
International clinical psychopharmacology 2009 Jul . Serretti A, Calati R, Massat I, Linotte S, Kasper S, Lecrubier Y, Sens-Espel R, Bollen J, Zohar J, Berlo J, Lienard P, De Ronchi D, Mendlewicz J, Souery D |
|
Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder.
Biological psychiatry 2009 May 65 (9): 785-91. Perlis Roy H, Fijal Bonnie, Adams David H, Sutton Virginia K, Trivedi Madhukar H, Houston John |
|
Steady-state concentrations of mirtazapine, N-desmethylmirtazapine, 8-hydroxymirtazapine and their enantiomers in relation to cytochrome P450 2D6 genotype, age and smoking behaviour.
Clinical pharmacokinetics 2009 48 (1): 63-70. Lind Anna-Britta, Reis Margareta, Bengtsson Finn, Jonzier-Perey Michele, Powell Golay Kerry, Ahlner Johan, Baumann Pierre, Dahl Marja-Lii |
|
Correlates of response to Olanzapine in a North Indian Schizophrenia sample.
Psychiatry research 2008 Dec 161 (3): 275-83. Thomas Pramod, Srivastava Vibhuti, Singh Anuradha, Mathur Priya, Nimgaonkar Vishwajit L, Lerer Bernard, Thelma B K, Deshpande Smita |
|
The relationship between the response of clinical symptoms and plasma olanzapine concentration, based on pharmacogenetics: Juntendo University Schizophrenia Projects (JUSP).
Therapeutic drug monitoring 2008 Feb 30 (1): 35-40. Nozawa Motohiro, Ohnuma Tohru, Matsubara Yoichiro, Sakai Yoshie, Hatano Tokiko, Hanzawa Ryo, Shibata Nobuto, Arai He |
|
Genetic susceptibility to Tardive Dyskinesia in chronic schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphism.
The pharmacogenomics journal 2007 Oct 7 (5): 305-11. Tiwari A K, Deshpande S N, Lerer B, Nimgaonkar V L, Thelma B |
|
Association of serotonin 2A receptor and lack of association of CYP1A2 gene polymorphism with tardive dyskinesia in a Turkish population.
DNA and cell biology 2007 Aug 26 (8): 527-31. Boke Omer, Gunes Sezgin, Kara Nurten, Aker Servet, Sahin Ahmet Rifat, Basar Yildiz, Bagci Has |
|
Functional polymorphisms of the cytochrome P450 1A2 (CYP1A2) gene and prolonged QTc interval in schizophrenia.
Progress in neuro-psychopharmacology & biological psychiatry 2007 Aug 31 (6): 1297-302. Tay Joshua K X, Tan Chay Hoon, Chong Siow-Ann, Tan Ene-Ch |
|
Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption.
The American journal of clinical nutrition 2007 Jul 86 (1): 240-4. Cornelis Marilyn C, El-Sohemy Ahmed, Campos Hann |
|
No effect of the CYP1A2*1F genotype on thioridazine, mesoridazine, sulforidazine plasma concentrations in psychiatric patients.
European journal of clinical pharmacology 2007 May 63 (5): 527-8. Dorado Pedro, Berecz Roland, Peñas-Lledó Eva M, de la Rubia Alfredo, Llerena Adri |
|
ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.
Clinical pharmacology and therapeutics 2006 Dec 80 (6): 668-81. Crettol Séverine, Déglon Jean-Jacques, Besson Jacques, Croquette-Krokar Marina, Hämmig Robert, Gothuey Isabelle, Monnat Martine, Eap Chin |
|
Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
Acta pharmacologica Sinica 2006 Mar 27 (3): 328-32. Fu Yan, Fan Chang-he, Deng He-huang, Hu San-hong, Lv De-peng, Li Li-hua, Wang Jun-jie, Lu Xin-qi |
|
Association study between functional polymorphisms in the cytochrome P450 1A2 and 2D6 genes and polydipsia in schizophrenia.
Neuromolecular medicine 2006 8 (3): 381-8. Matsumoto Chima, Shinkai Takahiro, De Luca Vincenzo, Hori Hiroko, Hwang Rudi, Ohmori Osamu, Kennedy James L, Nakamura J |
|
The cytochrome P450 CYP1A2 genetic polymorphisms *1F and *1D do not affect clozapine clearance in a group of schizophrenic patients.
Annals of clinical biochemistry 2005 May 42 (Pt 3): 216-9. Kootstra-Ros Jenny E, Smallegoor Windy, van der Weide J |
|
Genetic susceptibility to tardive dyskinesia in chronic schizophrenia subjects: I. Association of CYP1A2 gene polymorphism.
The pharmacogenomics journal 2005 5 (1): 60-9. Tiwari A K, Deshpande S N, Rao A R, Bhatia T, Mukit S R, Shriharsh V, Lerer B, Nimagaonkar V L, Thelma B |
|
Genetic association analysis of functional polymorphisms in the cytochrome P450 1A2 (CYP1A2) gene with tardive dyskinesia in Japanese patients with schizophrenia.
Psychiatric genetics 2004 Dec 14 (4): 209-13. Matsumoto Chima, Ohmori Osamu, Shinkai Takahiro, Hori Hiroko, Nakamura J |
|
No association between polymorphisms in three genes of cytochrome p450 family and paranoid schizophrenia in northern Chinese Han population.
European psychiatry : the journal of the Association of European Psychiatrists 2004 Sep 19 (6): 374-6. Jia Yanbin, Yu Xin, Zhang Boyu, Yuan Yanbo, Xu Qi, Shen Yucun, Shen Y |
|
Smoking and tardive dyskinesia: lack of involvement of the CYP1A2 gene.
Journal of psychiatry & neuroscience : JPN 2003 May 28 (3): 185-9. Chong Siow-Ann, Tan Ene-Choo, Tan Chay Hoon, Mythil |
|
Lack of impact of CYP1A2 genetic polymorphism (C/A polymorphism at position 734 in intron 1 and G/A polymorphism at position -2964 in the 5'-flanking region of CYP1A2) on the plasma concentration of haloperidol in smoking male Japanese with schizophrenia.
Progress in neuro-psychopharmacology & biological psychiatry 2002 Feb 26 (2): 261-5. Shimoda Kazutaka, Someya Toshiyuki, Morita Sachiyo, Hirokane Genta, Yokono Aya, Takahashi Saburo, Okawa Masa |
|
Lack of association between a functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene and tardive dyskinesia in schizophrenia.
American journal of medical genetics 2001 Aug 105 (6): 498-501. Schulze T G, Schumacher J, Müller D J, Krauss H, Alfter D, Maroldt A, Ahle G, Maroldt A O, Novo y Fernández A, Weber T, Held T, Propping P, Maier W, Nöthen M M, Rietschel |
|
Pharmacogenetic assessment of antipsychotic-induced movement disorders: contribution of the dopamine D3 receptor and cytochrome P450 1A2 genes.
Journal of biochemical and biophysical methods 2001 Jan 47 (1-2): 151-7. Ozdemir V, Basile V S, Masellis M, Kennedy J |
|
CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population.
Clinical neuropharmacology 0 42 (2): 32-36. Zhu Yuhao, Zhang Naixing, Ren Decheng, Bi Yan, Xu Fei, Niu Weibo, Sun Qianqian, Guo Zhenming, Yuan Ruixue, Yuan Fan, Wu Xi, Cao Yanfei, Yang Fengping, Wang Lu, Du Li, Li Weidong, Xu Yifeng, Li Xingwang, Zhu Liping, He Lin, Shi Lei, He Guang, Yu T |
- Page last reviewed:Jul 30, 2019
- Page last updated:Nov 14, 2019
- Content source: